Wird geladen...
Safety and Efficacy of Sorafenib Therapy in Patients With Metastatic Kidney Cancer With Impaired Renal Function
PURPOSE: Sorafenib is an oral Raf kinase inhibitor, approved for the treatment of advanced renal cancer. Clinical investigation of the safety and feasibility of sorafenib therapy in patients with impaired renal function was performed in this study. MATERIALS AND METHODS: The protocol was approved by...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3865860/ https://ncbi.nlm.nih.gov/pubmed/19692316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CGC.2009.n.015 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|